Abstract
REPLY: In response to our recent article evaluating the potential promise and current limitations of neuroimaging methods in contributing to the premortem diagnosis of limbic-predominant age-related TAR DNA-binding protein 43 (TDP-43) encephalopathy (LATE) ([ 1 ][1]), the letter by McCarter et al.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
